|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
German Clinical Trials Register |
|
Last refreshed on:
|
8 April 2024 |
|
Main ID: |
DRKS00010947 |
|
Date of registration:
|
10/08/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Differentiation of long-term neurological patients and implications for their care after hospital discharge
|
|
Scientific title:
|
Differentiation of long-term neurological patients and implications for their care after hospital discharge |
|
Date of first enrolment:
|
09/08/2016 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Complete |
|
URL:
|
http://drks.de/search/en/trial/DRKS00010947 |
|
Study type:
|
observational |
|
Study design:
|
Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: supportive care
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Contacts
|
|
Name:
|
Markus
Ebke |
|
Address:
|
Höhenstrasse 30
51588
Nümbrecht
Germany |
|
Telephone:
|
05222 398-870 |
|
Email:
|
mebke@t-online.de |
|
Affiliation:
|
Klinik für Neurologie, Dr. Becker Rhein-Sieg-Klinik |
|
|
Name:
|
Markus
Ebke |
|
Address:
|
Höhenstrasse 30
51588
Nümbrecht
Germany |
|
Telephone:
|
05222 398-870 |
|
Email:
|
mebke@t-online.de |
|
Affiliation:
|
Klinik für Neurologie, Dr. Becker Rhein-Sieg-Klinik |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Patients who are treated in neurorehabilitation, Phase B, C, D, aged 18-100Jahren
Exclusion criteria: Excluded are patients who themselves cannot give informed consent to the study and for whom no legalized authorized representative exists who could give informed consent instead.
Age minimum:
18 Years
Age maximum:
100 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Patients in neurorehabilitation Phase B, C, D
|
|
Intervention(s)
|
Group 1: Patients are assessed by a neurorehabilitation physician / a neurorehabilitation team as well as by a palliative care physician, not trained in neurorehabilitation using the surprise question ("Would you be surprised if this patient would die within the next 12 months?") and utilizing the palliative care basis assessment, HOPE-SP-CL. A telephone follow-up is planned to observe how far the assessment comes true and how patients’ health and living condition will develop.
|
|
Primary Outcome(s)
|
To test whether the surprise question is an appropriate measurement to predict the prognosis of neurorehabilitation patients.
This will be checked by a telephone follow up after 12 months (are patients still alive or not?).
|
|
Secondary Outcome(s)
|
Are there any differences in the assessment of the surprise question between a neurorehabilitation physician and a palliative care physician not trained in neurorehabilitation?
Which are the characteristics of neurorehabilitation patients who are still alive after one year or who have already died after one year, respectively?
Was the care organized by the neurorehabilitation team for the time after patients’ hospital discharge appropriate, or not?
A telephone follow-up (after 6, 12 months respectively) is planned to observe how far the assessment comes true and how patients’ health and living condition will develop.
|
|
Source(s) of Monetary Support
|
|
Klinik für Neurologie, Dr. Becker Rhein-Sieg-Klinik
|
|
Zentrum für Palliativmedizin, Uniklinik Köln
|
|
Ethics review
|
Status: Approved
Approval date: 01/08/2016
Contact:
medizinprodukte@aekno.de
Ethikkommission der Ärztekammer Nordrhein
+49-211-43021581
medizinprodukte@aekno.de
|
|